fbpx
Connect with us
  • Elysium

Neuro rehab technology

PoNS to be made available to patients remotely

Use of pioneering tech for MS patients will greatly widen access to patients across the United States

Published

on

Pioneering technology which supports people living with Multiple Sclerosis (MS) in improving gait impairment is now being made available for use remotely, widening access to patients. 

The Portable Neuromodulation Stimulator (PoNS) device is supporting people across the United States and Canada who live with MS to achieve life-changing improvements in their gait. 

Combined with an exercise regime supervised by a therapist, the PoNS – which delivers stimulation via the tongue – has been adopted by medical centres and therapists across both countries. 

But now, to help greater numbers of patients access the technology, the PoNS is being made available for the first time using telehealth. 

Its creator, Helius Medical Technologies, has partnered with UpScript to enable patients to order the device online for delivery to their home – a move hailed as being of huge importance for people facing challenges with their mobility.

“People want to remove the barriers keeping them from walking their best walk; we want to provide the tools and technology that can help them achieve that goal. That’s what this new telemedicine partnership is all about,” said Helius president and chief executive Dane Andreeff. 

“Our UpScript partnership simplifies and shortens the process of accessing healthcare providers and getting a PoNS device into the hands of people motivated to improve their walking. 

“And it speaks to our commitment to help patients take the fight against MS into their own hands.”

UpScript’s platform enables online health evaluations with qualified medical providers, fulfilment of prescriptions required for PoNS Therapy and shipping of PoNS devices directly to the homes of eligible patients in the US.

Although the ability to access quality healthcare providers and the PoNS device through telemedicine and without leaving home is new, the other critical component of PoNS therapy remains unchanged, say Helius. 

Those using the PoNS remotely must still work with a trained physical rehabilitation therapist. 

During the first two weeks of therapy, these experts work in-person with users, guiding them through therapeutic exercises designed to maximise the effectiveness of the device; for the following 12 weeks users continue the therapy at home, under their therapist’s supervision.

“People that have difficulty walking often face many challenges but leveraging cutting-edge neurologic technology that can improve their day-to-day life shouldn’t be one of them,” says Dane. 

“With our new telemedicine partnership, the journey to better walking now can start with just a few keystrokes. And both Helius and UpScript are committed to serving them as they move along that journey through customer support, as well.”

HIWIN

Trending